Effects of IGFBP4 deficiency on human preadipocyte proliferation and differentiation through the IGF1R/AKT pathway
Yujia Guo, Sandy Richter, Christoph Bach, Wieland Kiess, Anna Kirstein, Diana Le Duc, Antje Garten · 2026
Read Effects of IGFBP4 deficiency on human preadipocyte proliferation and differentiation through the IGF1R/AKT pathway by Yujia Guo, Sandy Richter, Christoph Bach, Wieland Kiess, Anna Kirstein, Diana Le Duc, Antje Garten (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13399132.txt.
Description
Guo and co-authors examine, in 2026, what the binding protein IGFBP4 does in human fat precursor cells, using knockdowns across adipocyte models including LipPD1 preadipocytes taken from an infant lipoma patient. IGFBP4 manages the growth factor IGF1. Silencing it slowed preadipocyte growth and reduced the IGF1 receptor and its activated downstream signal, phosphorylated AKT, while leaving fat-cell maturation untouched.
Adding purified IGFBP4 protein did not rescue the loss, a result hinting inside-cell IGFBP4 matters more than the supply in blood. When protein synthesis was blocked, the downregulation persisted unless a proteasome inhibitor was co-applied, pointing to proteasomal disposal as the mechanism rather than lysosomal routing. The authors propose that IGFBP4 keeps IGF1 at a level permitting healthy receptor trafficking and sustained AKT signaling. They nominate it as a therapeutic target for growth and metabolic disorders of IGF1R dysfunction.
Catalog record
| CREATOR | Yujia Guo, Sandy Richter, Christoph Bach, Wieland Kiess, Anna Kirstein, Diana Le Duc, Antje Garten |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 50 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |